Answers are grounded in this paper and cite their sources.
Quality monitoring in diagnostic-device manufacturing requires datasets that preserve temporal, hierarchical, and calibration-related structure while avoiding information leakage in predictive evaluation. This study presents the Diabetes-QMS Benchmark, a de-identified multi-level industrial dataset comprising 800 records: 70 completed glucose quality-control series, 690 HbA1c measurement-level records, and 40 HbA1c production-lot records collected between 2020 and 2026. Technical validation included statistical process control, leakage-aware classification analysis, production-lot-grouped and leave-one-year-out calibration evaluation, haematocrit-stratified bias assessment, conformal prediction, and lot-level anomaly screening. Glucose QC monitoring revealed increasing instability in the monitored quality-control indicators over time, with the most pronounced excursion occurring in 2025. Under production-lot-grouped validation, Random Forest calibration achieved performance numerically comparable with factory calibration (MAE 0.506 versus 0.541), whereas leave-one-year-out evaluation showed substantially poorer temporal generalisation of the static model. Conformal coverage similarly deteriorated under temporal shift, and calibration bias varied across haematocrit ranges. Lot-level analysis revealed pronounced temporal calibration drift and increased anomaly prevalence in 2025. The benchmark therefore provides a reusable resource for investigating manufacturing quality monitoring, temporal robustness, uncertainty quantification, anomaly screening, and leakage-aware machine learning under realistic industrial data constraints.
No takes yet. Share an insight, caveat, or question.
Karimkyzy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: